JAK1 and Alzheimer disease: Additionally, aberrantly expressed IL-10 in AD lesions activates the STAT1/STAT3 signaling axis via JAK1/TYK2, playing a pivotal role in regulating Th17/Th22 immune responses, which are more prominent in chronic AD.